Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
- | PE(38:5) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 117 | pmol/sample |
- | PE(38:5) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 152 | pmol/sample |
- | PE(38:5) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 170 | pmol/sample |
- | PE(38:5) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 153 | pmol/sample |
- | PE(38:5) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 161 | pmol/sample |
- | PE(38:5) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 171 | pmol/sample |
- | PE(38:5) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 269 | pmol/sample |
- | PE(38:5) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 224 | pmol/sample |
- | PE(38:5) | C | 0.0 | BCD100322A01 | 230 | pmol/sample |
- | PE(38:5) | C | 0.5 | BCD100322A03 | 179 | pmol/sample |
- | PE(38:5) | C | 1.0 | BCD100322A07 | 239 | pmol/sample |
- | PE(38:5) | C | 2.0 | BCD100322A11 | 264 | pmol/sample |
- | PE(38:5) | C | 4.0 | BCD100322A15 | 161 | pmol/sample |
- | PE(38:5) | C | 8.0 | BCD100322A19 | 192 | pmol/sample |
- | PE(38:5) | C | 12.0 | BCD100322A23 | 225 | pmol/sample |
- | PE(38:5) | C | 24.0 | BCD100322A27 | 317 | pmol/sample |
- | PE(38:5) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 187 | pmol/sample |
- | PE(38:5) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 342 | pmol/sample |
- | PE(38:5) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 328 | pmol/sample |
- | PE(38:5) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 152 | pmol/sample |
- | PE(38:5) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 175 | pmol/sample |
- | PE(38:5) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 200 | pmol/sample |
- | PE(38:5) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 305 | pmol/sample |
- | PE(38:5) | 25OH-Chol | 0.5 | BCD100322A04 | 173 | pmol/sample |
- | PE(38:5) | 25OH-Chol | 1.0 | BCD100322A08 | 266 | pmol/sample |
- | PE(38:5) | 25OH-Chol | 2.0 | BCD100322A12 | 239 | pmol/sample |
- | PE(38:5) | 25OH-Chol | 4.0 | BCD100322A16 | 191 | pmol/sample |
- | PE(38:5) | 25OH-Chol | 8.0 | BCD100322A20 | 200 | pmol/sample |
- | PE(38:5) | 25OH-Chol | 12.0 | BCD100322A24 | 206 | pmol/sample |
- | PE(38:5) | 25OH-Chol | 24.0 | BCD100322A28 | 468 | pmol/sample |